2 different management failed to commercialise wheezo in the US and this current one failed to commercialise here despite the large amount of money they spent on advertising and marketing (remember Michael Clarke).
Ann: $6.5m raised for US expansion, $20m commitment secured, page-78
Add RSH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.7¢ |
Change
0.003(8.82%) |
Mkt cap ! $39.21M | |||
| Open | High | Low | Value | Volume |
| 3.4¢ | 3.7¢ | 3.3¢ | $33.23K | 961.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 300000 | 3.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.7¢ | 66232 | 1 |
View Market Depth
| Last trade - 16.10pm 17/05/2024 (20 minute delay) ? |
|
|||||
|
Last
3.7¢ |
Change
0.003 ( 11.8 %) |
||||
| Open | High | Low | Volume | ||
| 3.4¢ | 3.7¢ | 2.9¢ | 75951 | ||
| Last updated 15.59pm 17/05/2024 ? | |||||
| RSH (ASX) Chart |